UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 4.257

Sortiert nach

Anti-PD-1 blockade with nivolumab with and without therapeutic vaccination for virally suppressed chronic hepatitis B: A pilot study

Journal of hepatology, 2019-11, Vol.71 (5), p.900-907

2019

Link zum Volltext

Verfügbarkeit prüfen

Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America

Hepatology (Baltimore, Md.), 2021-11, Vol.74 (5), p.2395-2409

2021

Link zum Volltext

Verfügbarkeit prüfen

Characterization and Application of Precore/Core‐Related Antigens in Animal Models of Hepatitis B Virus Infection

Hepatology (Baltimore, Md.), 2021-07, Vol.74 (1), p.99-115

2021

Link zum Volltext

Verfügbarkeit prüfen

Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study

Journal of hepatology, 2017-11, Vol.67 (5), p.918-924

2017

Link zum Volltext

Verfügbarkeit prüfen

Early inhibition of hepatocyte innate responses by hepatitis B virus

Journal of hepatology, 2015-12, Vol.63 (6), p.1314-1322

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical utility of HBV surface antigen quantification in HBV e antigen-negative chronic HBV infection

Nature reviews. Gastroenterology & hepatology, 2019-10, Vol.16 (10), p.631-641

Liaw, Yun-Fan

2019

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection

PLoS pathogens, 2019-04, Vol.15 (4), p.e1007690-e1007690

2019

Link zum Volltext

Verfügbarkeit prüfen

Letter: Association of persistently high HBsAg levels during HBeAg‐seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients

Alimentary pharmacology & therapeutics, 2024-06, Vol.59 (11), p.1457-1458

2024

Link zum Volltext

Verfügbarkeit prüfen

Letter: Association of persistently high HBsAg levels during HBeAg‐seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients—Authors' reply

Alimentary pharmacology & therapeutics, 2024-06, Vol.59 (11), p.1459-1461

2024

Link zum Volltext

Verfügbarkeit prüfen

Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naïve HBV-infected individuals

Journal of clinical virology, 2018-02, Vol.99-100, p.71-78

2018

Link zum Volltext

Verfügbarkeit prüfen

Peculiarities in the designations of hepatitis B virus genes, their products, and their antigenic specificities: a potential source of misunderstandings

Virus genes, 2020-04, Vol.56 (2), p.109-119

2020

Link zum Volltext

Verfügbarkeit prüfen

Systematic review with meta‐analysis: combination treatment of regimens based on pegylated interferon for chronic hepatitis B focusing on hepatitis B surface antigen clearance

Alimentary pharmacology & therapeutics, 2018-05, Vol.47 (10), p.1340-1348

2018

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of a nanoparticle therapeutic vaccine in patients with chronic hepatitis B: A randomized clinical trial

Hepatology (Baltimore, Md.), 2022-01, Vol.75 (1), p.182-195

2022

Link zum Volltext

Verfügbarkeit prüfen

Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks

PloS one, 2015-07, Vol.10 (7), p.e0131912-e0131912

2015

Link zum Volltext

Verfügbarkeit prüfen

Kinetics of Hepatitis B Core–Related Antigen and Anti–Hepatitis B Core Antibody and Their Association With Serological Response in Human Immunodeficiency Virus–Hepatitis B Coinfection

The Journal of infectious diseases, 2020-05, Vol.221 (11), p.1826-1837

2020

Link zum Volltext

Verfügbarkeit prüfen

Dynamic profile of the HBeAg-anti-HBe system in acute and chronic hepatitis B virus infection: A clinical-laboratory approach

Molecular biology reports, 2021, Vol.48 (1), p.843-854

de Almeida Pondé, Robério Amorim

2021

Link zum Volltext

Verfügbarkeit prüfen

Immune correlates of hepatitis B surface antigen spontaneous seroconversion in hepatitis B e antigen negative chronic hepatitis B patients

Liver international, 2018-01, Vol.38 (1), p.38-49

2018

Link zum Volltext

Verfügbarkeit prüfen

Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes

Alimentary pharmacology & therapeutics, 2018-04, Vol.47 (8), p.1170-1180

2018

Link zum Volltext

Verfügbarkeit prüfen

Maternal-Derived Hepatitis B Virus e Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence after Vertical Transmission

Immunity (Cambridge, Mass.), 2016-05, Vol.44 (5), p.1204-1214

2016

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B Flare After Cessation of Nucleos(t)ide Analogue Therapy in HBeAg‐Negative Chronic Hepatitis B: To Retreat or Not to Retreat

Hepatology (Baltimore, Md.), 2021-02, Vol.73 (2), p.843-852

Liaw, Yun‐Fan

2021

Link zum Volltext

Verfügbarkeit prüfen

A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women

Vaccine, 2012-08, Vol.30 (36), p.5335-5340

2012

Link zum Volltext

Verfügbarkeit prüfen

Correlation of HBV Core-Related Antigen with Conventional Serologic Indicators of Hepatitis B and Disease Stage

Clinical laboratory (Heidelberg), 2024-05, Vol.70 (5)

2024

Link zum Volltext

Verfügbarkeit prüfen

Identification and impact of hepatitis B virus DNA and antigens in pancreatic cancer tissues and adjacent non-cancerous tissues

Cancer letters, 2013-07, Vol.335 (2), p.447-454

2013

Link zum Volltext

Verfügbarkeit prüfen

Effects of traditional Chinese medicine formula Le-Cao-Shi on hepatitis B: In vivo and in vitro studies

Journal of ethnopharmacology, 2019-11, Vol.244, p.112132-112132, Article 112132

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 4.257

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.455)
Mit Volltextzugriff
(2.831)

Publikationsform

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(4.009)
Science & Technology
(2.855)
Life Sciences & Biomedicine
(2.750)
Female
(2.389)
Male
(2.300)
Adult
(2.064)
Middle Aged
(1.512)
Hepatitis B Virus - Immunology
(1.439)
Hepatitis B - Immunology
(1.391)
Hepatitis B Virus
(1.327)
Hepatitis B E Antigens - Blood
(1.293)
Hepatitis B Virus - Genetics
(1.288)
Biological And Medical Sciences
(1.267)
Infectious Diseases
(1.207)
Hepatitis B E Antigens - Immunology
(1.175)
Medical Sciences
(1.107)
Hepatitis B E Antigens - Analysis
(1.045)
Gastroenterology & Hepatology
(1.041)
Adolescent
(870)
Hepatitis B Surface Antigens - Analysis
(869)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Hepatology
(202)
Journal Of Medical Virology
(176)
Journal Of Hepatology
(147)
The Journal Of Infectious Diseases
(110)
Gastroenterology
(94)
Journal Of Viral Hepatitis
(87)
World Journal Of Gastroenterology : Wjg
(85)
Plos One
(83)
Journal Of Gastroenterology And Hepatology
(80)
Vaccine
(73)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Anti-PD-1 blockade with nivolumab with and without therapeutic vaccination for virally suppressed chronic hepatitis B: A pilot study

Comparison of HBV RNA and Hepatitis B Core Related Antigen With Conventional HBV Markers Among Untreated Adults With Chronic Hepatitis B in North America

Characterization and Application of Precore/Core‐Related Antigens in Animal Models of Hepatitis B Virus Infection

Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study

Early inhibition of hepatocyte innate responses by hepatitis B virus

Clinical utility of HBV surface antigen quantification in HBV e antigen-negative chronic HBV infection

Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection

Letter: Association of persistently high HBsAg levels during HBeAg‐seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients

Letter: Association of persistently high HBsAg levels during HBeAg‐seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients—Authors' reply

Serum HBV DNA plus RNA shows superiority in reflecting the activity of intrahepatic cccDNA in treatment-naïve HBV-infected individuals

Peculiarities in the designations of hepatitis B virus genes, their products, and their antigenic specificities: a potential source of misunderstandings

Systematic review with meta‐analysis: combination treatment of regimens based on pegylated interferon for chronic hepatitis B focusing on hepatitis B surface antigen clearance

Efficacy and safety of a nanoparticle therapeutic vaccine in patients with chronic hepatitis B: A randomized clinical trial

Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks

Kinetics of Hepatitis B Core–Related Antigen and Anti–Hepatitis B Core Antibody and Their Association With Serological Response in Human Immunodeficiency Virus–Hepatitis B Coinfection

Dynamic profile of the HBeAg-anti-HBe system in acute and chronic hepatitis B virus infection: A clinical-laboratory approach

Immune correlates of hepatitis B surface antigen spontaneous seroconversion in hepatitis B e antigen negative chronic hepatitis B patients

Stopping nucleos(t)ide analogue treatment in Caucasian hepatitis B patients after HBeAg seroconversion is associated with high relapse rates and fatal outcomes

Maternal-Derived Hepatitis B Virus e Antigen Alters Macrophage Function in Offspring to Drive Viral Persistence after Vertical Transmission

Hepatitis B Flare After Cessation of Nucleos(t)ide Analogue Therapy in HBeAg‐Negative Chronic Hepatitis B: To Retreat or Not to Retreat

A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women

Baseline quantitative hepatitis B core antibody titre alone strongly predicts HBeAg seroconversion across chronic hepatitis B patients treated with peginterferon or nucleos(t)ide analogues

Correlation of HBV Core-Related Antigen with Conventional Serologic Indicators of Hepatitis B and Disease Stage

Identification and impact of hepatitis B virus DNA and antigens in pancreatic cancer tissues and adjacent non-cancerous tissues

Effects of traditional Chinese medicine formula Le-Cao-Shi on hepatitis B: In vivo and in vitro studies

Suchergebnisse filtern